Skip to main navigation Skip to search Skip to main content

Overestimation of vancomycin concentrations utilizing fluorescence polarization immunoassay in patients on peritoneal dialysis

  • Bassett Healthcare
  • University of Toronto
  • SUNY Buffalo

Research output: Contribution to journal › Article › peer-review

61 Scopus citations

Abstract

During a study of vancomycin pharmacokinetics in patients undergoing continuous ambulatory peritoneal dialysis (CAPD), a discrepancy was noted when serum concentrations were determined by high performance liquid chromatography (HPLC) in comparison to a fluorescence polarization immunoassay (FPI) technique. Following three weekly intraperitoneal doses (30 mg/kg/2 L), peak serum concentrations (at the end of the 6-h dwell) by FPI were 42.1 ± 9.1, 43.1 ± 8.7, and 45.6 ± 7.4 |xg/ml. In comparison, the same samples when analyzed by HPLC yielded 36.3 ± 9.4, 32.2 ± 8.9, and 31.6 ± 9.1 fxg/ml, respectively. A subsequent in vitro study of vancomycin (40 (Jig/ml) in serum indicated a degradation half-life of 693 (FPI) compared with 210 (HPLC) h. These data suggest that vancomycin degradation products accumulate in CAPD patients and lead to an overestimation of vancomycin serurn concentrations when measured by FPI.

Original languageEnglish
Pages (from-to)212-215
Number of pages4
JournalTherapeutic Drug Monitoring
Volume9
Issue number2
DOIs
StatePublished - Jun 1987

Keywords

  • Continuous ambulatory peritoneal dialysis
  • Fluorescence polarization immunoassay
  • High performance liquid chromatography
  • Vancomycin

Fingerprint

Dive into the research topics of 'Overestimation of vancomycin concentrations utilizing fluorescence polarization immunoassay in patients on peritoneal dialysis'. Together they form a unique fingerprint.

Cite this